Similarities and Potential Differences
Antibodies are proteins made by the immune system in response to an infection or vaccination.
They are present on the surface of important cells of your immune system calledB cells.
Other immune cells called T cells help erase the infection.
FG Trade/E+/Getty Images
Antibody testscan detect the body’s levels of antibodies against a certain virus.
Thus, antibodies are a signal that an individual is likely protected from future infection.
However, it takes a while for this to work.
Neutralizing Antibodies
Antibodies attach very precisely to aspecific spoton a given virus.
But only attaching tosomeof these sites will actually inactivate the virus.
So for a vaccine to work, it must produce thisneutralizingantibody.
Antibody Types
The body usually first produces aspecific antibody typecalled IgM.
A little later, the body produces other types of antibodies.
An essential jot down is IgG antibodies.
These tend to last longer than IgM antibodies.
Recap
Antibodies trigger your immune system to fight infection.
They connect to a specific spot on a virus to inactivate it.
IgM antibodies are the first antibodies the body produces.
Later, your body makes IgG antibodies.
These are critical for preventing future infection.
When this happens, you dont get sick.
Or, if you do get sick, you usually only get a very mild version of an illness.
This is called protective immunity to a disease.
Depending on the situation, this immunity might last for months or years.
You might also have partial immunity.
COVID-19 Antibodies
Antibodies have a key role in treating infection and preventing disease.
That’s why scientists have been so interested in understanding the role of antibodies in COVID-19.
While some trials continue,the World Health Organization does not currently recommend it.
Several monoclonal antibody products received EUA by the FDA, but most of these EUAs were later revoked.
Vaccines
Studying how antibodies work in COVID-19 has also been critical for developing successful vaccines.
This knowledge is also important for assessing how immunity to COVID-19either from infection or a vaccinedecreases over time.
This will help scientists determine when people need booster vaccine shots to re-up their immunity.
First, it goes through a process of identifying the virus and eventually making effective antibodies.
Your B cells make antibodies to different parts of the virus.
Some of the antibodies your body makes are effective, and some are not.
These help you eliminate the virus and recover.
Hopefully, some of these antibodies also help protect you from future infections.
A study published in March 2022 compared unvaccinated people who had and had not been previously infected with COVID-19.
Those previously infected were 86% less likely to be reinfected.
However, protection waned more than one year after infection.
However, these data were compiled before the advent of the delta and omicron variants.
Since these variants are more contagious, this reinfection rate may now be higher.
These results reflect data from the delta variant, but the omicron variant was not included in the study.
Studies have indicated that people with symptoms of COVID-19 also seem to produce effective neutralizing antibodies.
In fact, contracting COVID and then getting vaccinated appears to produce the most robust protection against later reinfection.
How Long Might Natural Immunity Last?
How long protective immunity lasts after infection varies for different types of viruses.
Some viruses mutate (change) rather quickly.
This is why a new flu vaccine is created each year.
Immunity to some types of coronavirus may be short-lived.
For example, people can get cold-like symptoms from certain coronaviruses season after season.
But coronaviruses dont mutate as rapidly as viruses like the flu.
This may mean that protective immunity could last longer for COVID-19 than it does for something like the flu.
Antibodies to COVID-19 do appear to decrease in the months after infection.
However, that happens for all infectious diseases.
Therefore, it doesnt necessarily mean that immune protection is decreasing.
B cells may decrease their antibody production in the months after infection.
But memory B cells can continue to circulate in the bloodstream for years.
Presumably, these B cells could start releasing the neutralizing antibody if they were again exposed to the virus.
For example, they might look for a certain concentration of a specific antibody.
However, researchers have been gathering data on what immunity looks like.
They also found elderly people had less antibody response.
Naturally acquired immunity happens after becoming infected with a particular illness.
This usually protects from reinfection, at least in the short term.
How long natural immunity lasts depends on the virus and how quickly it mutates.
Different types of vaccines do this in different ways.
These antibodies stop the virus before you get sick.
Or, in some cases, you might get sick but with a much milder case.
Thats because your immune system already has a head startone it wouldnt have had if you hadnt been vaccinated.
And just like in a natural infection,protective immunity doesnt begin the moment you get vaccinated.
Thats why you dont get full protective coverage from a vaccination right away.
One difference is that certain types of vaccines only show the immune systempartof the relevant virus.
However, this doesnt mean that the antibodies formed are less effective than those formed in a natural infection.
It can also tell if they have been successfully vaccinated.
Most of the vaccines for COVID-19only show the immune system part of the virus.
This is a protein chosen to trigger a strong immune response.
(This includes thePfizer,Moderna, andNovavaxvaccines.)
The difference between vaccine-acquired and naturally acquired immunity is a very complex topic.
You cant just compare natural infection to vaccination because not every vaccine has the same properties.
In addition, not every vaccine will trigger the same immune response.
This is especially true if a vaccine has been designed to provoke a strong response.
We cant make assumptions without studying the specific data over the long term.
Vaccines introduce your body to proteins from a virus.
As a result, vaccination helps you avoid getting sick or getting severely ill.
Vaccine immunity and natural immunity can differ in the types of antibodies produced against a virus.
However, they both work to prepare the body’s immune system with antibodies to fight disease.
Potential Risks of Antibodies
Antibodies provide many benefits.
They eliminate infections and provide protective immunity against future infections.
However, in rare circumstances, antibodies might actually worsen an infection.
This scenario has been called antibody-dependent enhancement.It has been found in viruses such asdengue.
In that virus, it complicated the creation of successful vaccines.
However,no signs of antibody-dependent enhancement have been found in COVID-19.
The vaccines have been highly effective at preventing infection and severe illness.
This will help determine when booster vaccines are necessary.
“Breakthrough” casesinfection after vaccinationhave also become more common with new variants of the virus that causes COVID-19.
Summary
Antibodies help your body fight off certain infections.
They work when your body is actively ill.
They also stick around to help prevent you from becoming re-infected.
Vaccines are another way your body can acquire antibodies.
Vaccines introduce your body to one or more proteins from a virus.
This prompts it to make B cells, which produce antibodies against a specific virus.
Vaccines are a safe and effective way to protect yourself from infectious diseases.
COVID-19 vaccines are the safest way to protect yourself from COVID-19.
They are widely available to everyone 6 months and older.
Forthal DN.Functions of antibodies.Microbiol Spectr.
2014;2(4):1-17. doi:10.1128/microbiolspec.AID-0019-2014
Kadkhoda K.COVID-19 serologic testing: FAQs and caveats.Cleve Clin J Med.
2020 Jun;87(6):329-333. doi:10.3949/ccjm.87a.20054
Davison SA, Strasser SI.Ordering and interpreting hepatitis B serology.BMJ.
2014 Apr 17;348:g2522.
doi:10.1136/bmj.g2522
Siegrist C. Chapter 2: Vaccine Immunology.Plotkins Vaccines.
Centers for Disease Control and the Infectious Disease Society of America.Convalescent plasma.
November 17, 2020.
National Institutes of Health.NIH study shows no significant benefit of convalescent plasma for COVID-19 outpatients with early symptoms.
August 18, 2021.
World Health Organization.WHO recommends against the use of convalescent plasma to treat COVID-19.
December 7, 2021.
Centers for Medicare & Medicaid Services.COVID-19 Monoclonal Antibodies.
Hall V, et al.Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection.N Engl J Med.
2022 Mar 31;386(13):1207-1220. doi:10.1056/NEJMoa2118691.
Townsend JP, et al.The Durability of Immunity Against Reinfection by SARS-CoV-2: A Comparative Evolutionary Study.Lancet Microbe.
2021 Dec;2(12):e666-e675.
doi:10.1016/S2666-5247(21)00219-6.
2022 Jan 31;17(1):e0263014.
2022 Feb 15:M21-4130.
Epub ahead of print.
Hall V, et al.Protection against SARS-CoV-2 after Covid-19 Vaccination and Previous Infection.NEngl J Med.
2022 Mar 31;386(13):1207-1220. doi:10.1056/NEJMoa2118691.
American College of Rheumatology.
The Rheumatologist.ACR Convergence 2020: Progress toward COVID-19 vaccines.
November 11, 2020.
Spellberg B, Nielsen TB, Casadevall A.Antibodies, immunity, and COVID-19.JAMA Intern Med.
2020 Nov 24. doi:10.1001/jamainternmed.2020.7986
Baraniuk C.How long does covid-19 immunity last?.BMJ.
2020 Oct 8;5(52):eabe5511.
2021;10:100208. doi:10.1016/j.lanepe.2021.100208
Centers for Disease Control and Prevention.Covid Data Tracker.
